| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/16/2003 | US20030012781 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 01/16/2003 | US20030012772 Methods for improving cell line activity in immunoisolation devices |
| 01/16/2003 | US20030012770 Recombinant p53 adenovirus methods and compositions |
| 01/16/2003 | US20030012767 Tissue-specific taanscriptional regulatory sequence operably linked to the coding region of a gene that is essential for replication of said vector. |
| 01/16/2003 | DE20210068U1 Externally applied emulsion for treating skin irritation, eczema, wound sites or injuries, containing synergistic combination of emu oil and beta-glucan or derivative |
| 01/16/2003 | CA2453173A1 Mycobacterial antigens expressed during latency |
| 01/16/2003 | CA2452695A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | CA2452651A1 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 01/16/2003 | CA2452119A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | CA2451741A1 Peyers's patch and/or m-celle targeting ligands |
| 01/16/2003 | CA2451055A1 Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours |
| 01/16/2003 | CA2441416A1 Human secreted proteins |
| 01/15/2003 | EP1275716A2 Modified DNA molecule, recombinant containing the same thing, and uses thereof |
| 01/15/2003 | EP1275426A1 Device comprising a surface coated with a defoaming agent and use of a surface coated with a defoaming agent |
| 01/15/2003 | EP1275410A2 A blood filter |
| 01/15/2003 | EP1275400A1 Therapeutic composition of non MHC-restricted T-cells/NK-cells and MHC-restricted cells for the treatment of tumors |
| 01/15/2003 | EP1275397A2 Medicament for local use |
| 01/15/2003 | EP1274840A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/15/2003 | EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2003 | EP1274833A2 A method to prevent graft rejection using tgf-beta to induce t suppressor cells |
| 01/15/2003 | EP1274832A1 L-leucyl-l-leucine methyl ester treatment of donor lypmhocyte infusions in hematopoietic stem cell transplant patients |
| 01/15/2003 | EP1274733A1 Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor |
| 01/15/2003 | EP1274721A1 Haemostatically active preparation containing vwf and method for the production thereof |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274466A1 Composition for detecting beta-1,3-glucan, preparation method thereof and diagnostic kit detecting beta-1,3-glucan |
| 01/15/2003 | EP1274464A2 Compositions and methods for regulated protein expression in gut |
| 01/15/2003 | EP1274451A1 Sperm factor oscillogenin |
| 01/15/2003 | EP1274448A1 Method for improving the quality of sperm for artificial insemination of animals |
| 01/15/2003 | EP1121929A4 Drug preparation "histochrome" for treating ocular conditions |
| 01/15/2003 | EP1056835A4 Derivation of cells and tissues from embryonic pre-stem cells for transplantation therapies |
| 01/15/2003 | EP0967862B1 Methods and compositions for producing dried, storage-stable platelets |
| 01/15/2003 | CN1391609A Use of replication-deficient adenoviral vector to boost CD8+T cell immune response to antigen |
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391605A Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 01/15/2003 | CN1391481A 疫苗 Vaccine |
| 01/15/2003 | CN1391480A Compositions and methods for treatment of allergic disorders |
| 01/15/2003 | CN1391464A Formulation for menopausal women |
| 01/15/2003 | CN1390601A Composite medicine for treating mastoplasia and its preparing process |
| 01/15/2003 | CN1390600A Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process |
| 01/15/2003 | CN1390598A Medicine made of lysimachia for treating hepatobiliary calculus and its prescription |
| 01/15/2003 | CN1390597A Medicine made of chuan-xing rhizome for treating thromboangitis obliterans and its presciption |
| 01/15/2003 | CN1390596A Mayi-shuangshen Tongbi pill for treating rheumatoid or rheumatic arthitis and ankylosing spondylitis |
| 01/15/2003 | CN1390593A Chinese-medicinal ointment for treating burn |
| 01/15/2003 | CN1390588A Composite medicine for treating leukemia |
| 01/15/2003 | CN1390586A Plaster fr treating facial paralysis |
| 01/15/2003 | CN1390585A Chinese medicine for detoxication purpose and its preparing process |
| 01/15/2003 | CN1390577A Pill of tortoise plastron and turtle shell |
| 01/15/2003 | CN1390576A Exterior-applied medicine for treating rhinitis and nasosinusitis |
| 01/15/2003 | CN1390574A Medicine for delaying senility and its preparing process |
| 01/15/2003 | CN1390573A Chinese patent medicine for treating leukodema |
| 01/15/2003 | CN1390567A Chinese medicine for treating icterohepatitis |
| 01/15/2003 | CN1390562A Chinese medicine for treating burn and scald and its preparing process |
| 01/15/2003 | CN1390559A Mossback capsule and its preparing process |
| 01/15/2003 | CN1390558A Oral liquid made of mossback and its preparing process |
| 01/15/2003 | CN1390557A Mossback capsule for building up body and its preparing process |
| 01/15/2003 | CN1390552A Health-care mineral food and its preparing process |
| 01/15/2003 | CN1390465A Colostrum extract enriched composite powder |
| 01/15/2003 | CN1098706C Medicine for curing coronary heart disease |
| 01/15/2003 | CN1098705C Oral medicine for diseases of cranial nerves system and preparing method thereof |
| 01/15/2003 | CN1098704C Preparation of hemiplegia treating capsule |
| 01/15/2003 | CN1098703C Medical capsule for building up body and invigorating function of kidney |
| 01/15/2003 | CN1098701C Medicine for cardio-cerebral angiopathy |
| 01/15/2003 | CN1098700C Chinese patent medicine for treating piles |
| 01/15/2003 | CN1098699C Fushuixiao oral liquor (medicine for elimianting ascites) and preparing process |
| 01/15/2003 | CN1098695C Chinese medicinal composition for treating asthma and preparing process thereof |
| 01/15/2003 | CN1098694C Exterior-applied Chines medicine for treating aftos |
| 01/15/2003 | CN1098693C Chinese patent medicine for curing gastric ulcer |
| 01/15/2003 | CN1098692C Medicine for treating craniocerebral trauma and intracranial hematoma and its preparing process |
| 01/15/2003 | CN1098691C Propolis honey and its preparing process |
| 01/15/2003 | CN1098690C Microencapsulated bovine adrenal medulla chromaffincell medicine used for treating Parkinson's disease |
| 01/15/2003 | CN1098677C Nutritive beautifying skin-protecting preparation containing colostrum fat of cow |
| 01/14/2003 | US6506599 Method for culturing langerhans islets and islet autotransplantation islet regeneration |
| 01/14/2003 | US6506582 Extended by aspartic acid at 5' end and shortened at 3' end by one to eight amino acids; nonimmunogenic; binds CD4 lymphocytes |
| 01/14/2003 | US6506574 Drug screening, liver replenishment; culturing with cellular differentiation agent |
| 01/14/2003 | US6506420 Combinations of psyllium and chitosan for synergistic adsorption of triglyceride |
| 01/14/2003 | US6506415 Method of inducing resistance to tumor growth |
| 01/14/2003 | US6506414 Homogenizing a tissue in a nondenaturing aqueous solvent to obtain particles; aqueous solvent extraction; separation of solid and liquid; fractionating and purifying; inhibitors of matrix metalloprotease and angiogenesis; antitumor agents |
| 01/14/2003 | US6506408 Implantable or insertable therapeutic agent delivery device |
| 01/14/2003 | US6506398 Device for treating diabetes and methods thereof |
| 01/14/2003 | US6506388 Treating pollinosis using substance obtained by dissolving cell wall of corynebacterlum glutamicum with one of glucosi-dase and endopeptidase in isotonic solution medium, separa-ting protoplasts and treating with the other enzyme |
| 01/14/2003 | US6506381 Modified red blood cell that has surface molecules that neutralize chemical agents |
| 01/14/2003 | US6506380 Methods of preventing or treating allergies |
| 01/09/2003 | WO2003002173A1 Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications |
| 01/09/2003 | WO2003002155A1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 01/09/2003 | WO2003002140A1 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy |
| 01/09/2003 | WO2003002137A2 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/09/2003 | WO2003002131A1 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic |
| 01/09/2003 | WO2003002128A1 Methods and compositions for treatment of gastric diseases |
| 01/09/2003 | WO2003002044A2 Method of inhibiting the proliferation of vascular smooth muscle cells |
| 01/09/2003 | WO2003001981A2 Method of promoting engraftment of a donor transplant in a recipient host |
| 01/09/2003 | WO2003001927A1 Capsules containing vital cells or tissues |
| 01/09/2003 | WO2002092825A3 Retroviral vectors for gene therapy |
| 01/09/2003 | WO2002087612A3 Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases |
| 01/09/2003 | WO2002051443A3 Aqueous gel comprising a gelling agent such as kappa carrageenan and at least 85 % water |
| 01/09/2003 | WO2002046373A9 Method of collecting placental stem cells |
| 01/09/2003 | WO2002032953A3 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 01/09/2003 | WO2001090390A9 Use of baculovirus vectors in gene therapy |
| 01/09/2003 | WO2001079480A9 Albumin fusion proteins |
| 01/09/2003 | WO2001009609A3 Hepatitis c viral antigen immunoassay detection systems |